🇺🇸 Nomegestrol Acetate / Estradiol in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 12

Most-reported reactions

1. Deep Vein Thrombosis — 2 reports (16.67%)
2. Urticaria — 2 reports (16.67%)
3. Acne — 1 report (8.33%)
4. Alopecia — 1 report (8.33%)
5. Depression — 1 report (8.33%)
6. Dizziness — 1 report (8.33%)
7. Ectopic Pregnancy — 1 report (8.33%)
8. Hypersensitivity — 1 report (8.33%)
9. Ligament Rupture — 1 report (8.33%)
10. Nausea — 1 report (8.33%)

Source database →

Frequently asked questions

Is Nomegestrol Acetate / Estradiol approved in United States?

Nomegestrol Acetate / Estradiol does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Nomegestrol Acetate / Estradiol in United States?

University of Palermo is the originator. The local marketing authorisation holder may differ — check the official source linked above.